BRAIN MONITORING MARKET ANALYSIS

Brain Monitoring Market, By Product Type (Magnetoencephalograph, Electroencephalograph Cerebral Oximeters, Functional Magnetic Resonance Imaging (fMRI), Intracranial pressure Monitoring Devices, and Other Product Types), By Application (Parkinson’s Disease, Traumatic Brain Injury Epilepsy, Dementia, and Sleep Disorders Other Applications), By End User (Hospitals and Diagnostic Centers), and By Geography (North America, Europe, Asia Pacific, Middle East and Africa, and Latin America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Published In : Jan 2023
Code : CMI165
Pages :168
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Brain Monitoring Market: Key Developments

In February 2020, Compumedics Limited received 510(K) clearance from the U.S. Food and Drug Administration (FDA) for Orion LifeSpan Magnetoencephalography (MEG) single Dewar system.

In October 2019, Medtronic launched the FDA- approved deep brain stimulation device in the U.S. that uses a surgically implanted medical stimulator to deliver electric pulses directly to the brain.

In September 2019, Integra LifeSciences acquired privately-held Rebound Therapeutics to expand the portfolio of neurosurgery products.

In March 2018, Nihon Kohden launched aireeg WEE-1200 wireless electroencephalogram (EEG) system designed specifically for patient comfort and easy access to real-time patient data during long-term epilepsy monitoring, intensive care, and routine EEG environments.